Review



rgpx4  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    OriGene rgpx4
    TXNDC12 inhibits ferroptosis independent on GPX4 (A) The protein expression of GPX4 was analyzed by western blot in indicated K562 cells with or without GPX4 overexpression. (B) Cell death analysis was performed on the indicated K562 cells with or without GPX4 overexpression in response to erastin (10 μM) or RSL3 (0.5 μM) for 4–24 h. (C) The levels of MDA were analyzed in the indicated K562 cells with or without GPX4 overexpression in response to erastin (10 μM) or RSL3 (0.5 μM) for 24 h. (D) The protein expression of TXNDC12 was analyzed by western blot in indicated WT and Gpx4 -knockout Pfa-1 cells with or without Txndc12 overexpression. (E) Cell death analysis was performed on the indicated Pfa-1 cells with or without Txndc12 overexpression. (F) The levels of MDA were analyzed in the indicated Pfa-1 cells at 72 h. (G) Cell death analysis was performed on the indicated Pfa-1 cells in response to erastin (5 μM) for 24 h. The data represent the means ± SD from three independent samples. Statistical analysis was performed using two-way ANOVA with Tukey’s multiple comparisons test. ∗p < 0.05 versus WT group. (H) IP analysis was performed on K562 cells in response to erastin (10 μM) for 12 h. (I) Fluorescent calcein dye was entrapped within liposomes, which were subsequently exposed to Fe 2+ (10 μM) under conditions either with or without the presence of ferrostain-1 (1 μM), <t>rGPX4</t> (200 nM), or rTXNDC1 (200 nM) for a duration of 20 min. The release of calcein from the liposomes was assessed by measuring changes in calcein fluorescence intensity. The data represent the means ± SD from three independent samples. Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparisons test. ∗p < 0.05 versus Fe group.
    Rgpx4, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gpx4/Glutathione+Peroxidase+4+(GPX4)+(NM_002085)+Human+Recombinant+Protein/pmc10690572-33-0-2
    Average 91 stars, based on 1 article reviews
    rgpx4 - by Bioz Stars, 2026-09
    91/100 stars

    Images

    1) Product Images from "TXNDC12 inhibits lipid peroxidation and ferroptosis"

    Article Title: TXNDC12 inhibits lipid peroxidation and ferroptosis

    Journal: iScience

    doi: 10.1016/j.isci.2023.108393

    TXNDC12 inhibits ferroptosis independent on GPX4 (A) The protein expression of GPX4 was analyzed by western blot in indicated K562 cells with or without GPX4 overexpression. (B) Cell death analysis was performed on the indicated K562 cells with or without GPX4 overexpression in response to erastin (10 μM) or RSL3 (0.5 μM) for 4–24 h. (C) The levels of MDA were analyzed in the indicated K562 cells with or without GPX4 overexpression in response to erastin (10 μM) or RSL3 (0.5 μM) for 24 h. (D) The protein expression of TXNDC12 was analyzed by western blot in indicated WT and Gpx4 -knockout Pfa-1 cells with or without Txndc12 overexpression. (E) Cell death analysis was performed on the indicated Pfa-1 cells with or without Txndc12 overexpression. (F) The levels of MDA were analyzed in the indicated Pfa-1 cells at 72 h. (G) Cell death analysis was performed on the indicated Pfa-1 cells in response to erastin (5 μM) for 24 h. The data represent the means ± SD from three independent samples. Statistical analysis was performed using two-way ANOVA with Tukey’s multiple comparisons test. ∗p < 0.05 versus WT group. (H) IP analysis was performed on K562 cells in response to erastin (10 μM) for 12 h. (I) Fluorescent calcein dye was entrapped within liposomes, which were subsequently exposed to Fe 2+ (10 μM) under conditions either with or without the presence of ferrostain-1 (1 μM), rGPX4 (200 nM), or rTXNDC1 (200 nM) for a duration of 20 min. The release of calcein from the liposomes was assessed by measuring changes in calcein fluorescence intensity. The data represent the means ± SD from three independent samples. Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparisons test. ∗p < 0.05 versus Fe group.
    Figure Legend Snippet: TXNDC12 inhibits ferroptosis independent on GPX4 (A) The protein expression of GPX4 was analyzed by western blot in indicated K562 cells with or without GPX4 overexpression. (B) Cell death analysis was performed on the indicated K562 cells with or without GPX4 overexpression in response to erastin (10 μM) or RSL3 (0.5 μM) for 4–24 h. (C) The levels of MDA were analyzed in the indicated K562 cells with or without GPX4 overexpression in response to erastin (10 μM) or RSL3 (0.5 μM) for 24 h. (D) The protein expression of TXNDC12 was analyzed by western blot in indicated WT and Gpx4 -knockout Pfa-1 cells with or without Txndc12 overexpression. (E) Cell death analysis was performed on the indicated Pfa-1 cells with or without Txndc12 overexpression. (F) The levels of MDA were analyzed in the indicated Pfa-1 cells at 72 h. (G) Cell death analysis was performed on the indicated Pfa-1 cells in response to erastin (5 μM) for 24 h. The data represent the means ± SD from three independent samples. Statistical analysis was performed using two-way ANOVA with Tukey’s multiple comparisons test. ∗p < 0.05 versus WT group. (H) IP analysis was performed on K562 cells in response to erastin (10 μM) for 12 h. (I) Fluorescent calcein dye was entrapped within liposomes, which were subsequently exposed to Fe 2+ (10 μM) under conditions either with or without the presence of ferrostain-1 (1 μM), rGPX4 (200 nM), or rTXNDC1 (200 nM) for a duration of 20 min. The release of calcein from the liposomes was assessed by measuring changes in calcein fluorescence intensity. The data represent the means ± SD from three independent samples. Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparisons test. ∗p < 0.05 versus Fe group.

    Techniques Used: Expressing, Western Blot, Over Expression, Knock-Out, Liposomes, Fluorescence


    Figure Legend Snippet:

    Techniques Used: Recombinant, Lysis, Bicinchoninic Acid Protein Assay, CCK-8 Assay, Transfection, Reporter Assay, Iron Assay, Multiple Displacement Amplification, Magnetic Beads, Mutagenesis, Chromatin Immunoprecipitation, Purification, Enzyme-linked Immunosorbent Assay, shRNA, Software

    Related Articles

    Liposomes:

    Article Title: TXNDC12 inhibits lipid peroxidation and ferroptosis
    Article Snippet: The free calcein was removed by gel filtration on a Sephadex G-50 column (GE Healthcare, 17004201), and the liposomes were collected and adjusted to a lipid concentration of 0.8 mg/mL before use. .. The liposomes were incubated with Fe 2+ (10 μM) under conditions either with or without the presence of ferrostain-1 (1 μM), rGPX4 (200 nM; TP762179, OriGene), or rTXNDC12 (200 nM; TP303511, OriGene) for a duration of 20 minutes. ..

    Incubation:

    Article Title: TXNDC12 inhibits lipid peroxidation and ferroptosis
    Article Snippet: The free calcein was removed by gel filtration on a Sephadex G-50 column (GE Healthcare, 17004201), and the liposomes were collected and adjusted to a lipid concentration of 0.8 mg/mL before use. .. The liposomes were incubated with Fe 2+ (10 μM) under conditions either with or without the presence of ferrostain-1 (1 μM), rGPX4 (200 nM; TP762179, OriGene), or rTXNDC12 (200 nM; TP303511, OriGene) for a duration of 20 minutes. ..



    Similar Products

    94
    MedChemExpress gpx4
    Gpx4, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gpx4/GPX4+Antibody/pm42126735-78-33-35
    Average 94 stars, based on 1 article reviews
    gpx4 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    99
    MedChemExpress rsl3
    Rsl3, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gpx4/RSL3/custom%40hy-100218a%4042603824
    Average 99 stars, based on 1 article reviews
    rsl3 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    86
    Abmart Inc antibodies against gpx4
    The <t>SLC1A5-GPX4</t> axis mediates lapatinib-induced ferroptosis. (A-B) Western blot analysis of SLC1A5 protein expression in OS cells treated with Lap or Lap+DFO (100 μM). (C) Evaluation of the interaction between Lap and SLC1A5 using CETSA. (D) DARTS assay confirming the interaction between Lap and SLC1A5. (E) Viability assessment by calcein-AM (live, green)/PI (dead, red) staining in cells overexpressing SLC1A5. (F) Detection of intracellular Fe 2+ by FerroOrange probe. (G-H) Measurements of Gln and GSH levels in OS cells under indicated conditions. (I) Western blot analysis of SLC1A5 and GPX4 expression following Lap treatment in SLC1A5-overexpressing cells. (J) Western blot analysis of SLC1A5 protein expression in OS cells transfected with control siRNA or siRNA SLC1A5, showing knockdown efficiency. (K) GPX4 protein expression after lapatinib treatment for 24 h in control and SLC1A5 knockdown cells. (L) Cell viability determined by CCK-8 assay. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Antibodies Against Gpx4, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gpx4/anti+gpx4/pmc13273694-111-22-26
    Average 86 stars, based on 1 article reviews
    antibodies against gpx4 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    94
    MedChemExpress gpx4-in-3
    The <t>SLC1A5-GPX4</t> axis mediates lapatinib-induced ferroptosis. (A-B) Western blot analysis of SLC1A5 protein expression in OS cells treated with Lap or Lap+DFO (100 μM). (C) Evaluation of the interaction between Lap and SLC1A5 using CETSA. (D) DARTS assay confirming the interaction between Lap and SLC1A5. (E) Viability assessment by calcein-AM (live, green)/PI (dead, red) staining in cells overexpressing SLC1A5. (F) Detection of intracellular Fe 2+ by FerroOrange probe. (G-H) Measurements of Gln and GSH levels in OS cells under indicated conditions. (I) Western blot analysis of SLC1A5 and GPX4 expression following Lap treatment in SLC1A5-overexpressing cells. (J) Western blot analysis of SLC1A5 protein expression in OS cells transfected with control siRNA or siRNA SLC1A5, showing knockdown efficiency. (K) GPX4 protein expression after lapatinib treatment for 24 h in control and SLC1A5 knockdown cells. (L) Cell viability determined by CCK-8 assay. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Gpx4 In 3, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gpx4/GPX4-IN-3/custom%40hy-141809%4010%2E1016%2Fj%2Ephymed%2E2026%2E158563
    Average 94 stars, based on 1 article reviews
    gpx4-in-3 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    96
    Proteintech gpx4
    The <t>SLC1A5-GPX4</t> axis mediates lapatinib-induced ferroptosis. (A-B) Western blot analysis of SLC1A5 protein expression in OS cells treated with Lap or Lap+DFO (100 μM). (C) Evaluation of the interaction between Lap and SLC1A5 using CETSA. (D) DARTS assay confirming the interaction between Lap and SLC1A5. (E) Viability assessment by calcein-AM (live, green)/PI (dead, red) staining in cells overexpressing SLC1A5. (F) Detection of intracellular Fe 2+ by FerroOrange probe. (G-H) Measurements of Gln and GSH levels in OS cells under indicated conditions. (I) Western blot analysis of SLC1A5 and GPX4 expression following Lap treatment in SLC1A5-overexpressing cells. (J) Western blot analysis of SLC1A5 protein expression in OS cells transfected with control siRNA or siRNA SLC1A5, showing knockdown efficiency. (K) GPX4 protein expression after lapatinib treatment for 24 h in control and SLC1A5 knockdown cells. (L) Cell viability determined by CCK-8 assay. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Gpx4, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gpx4/GPX4+Antibody/pmc12933830-167-17-18
    Average 96 stars, based on 1 article reviews
    gpx4 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    94
    MedChemExpress gpx4 in 3
    The <t>SLC1A5-GPX4</t> axis mediates lapatinib-induced ferroptosis. (A-B) Western blot analysis of SLC1A5 protein expression in OS cells treated with Lap or Lap+DFO (100 μM). (C) Evaluation of the interaction between Lap and SLC1A5 using CETSA. (D) DARTS assay confirming the interaction between Lap and SLC1A5. (E) Viability assessment by calcein-AM (live, green)/PI (dead, red) staining in cells overexpressing SLC1A5. (F) Detection of intracellular Fe 2+ by FerroOrange probe. (G-H) Measurements of Gln and GSH levels in OS cells under indicated conditions. (I) Western blot analysis of SLC1A5 and GPX4 expression following Lap treatment in SLC1A5-overexpressing cells. (J) Western blot analysis of SLC1A5 protein expression in OS cells transfected with control siRNA or siRNA SLC1A5, showing knockdown efficiency. (K) GPX4 protein expression after lapatinib treatment for 24 h in control and SLC1A5 knockdown cells. (L) Cell viability determined by CCK-8 assay. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Gpx4 In 3, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gpx4/GPX4-IN-3/10__1016_slash_j__phymed__2026__158563-74-14-21
    Average 94 stars, based on 1 article reviews
    gpx4 in 3 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    86
    Nanjing Jiancheng Bioengineering Research Institute Co Ltd assays gpx4 activity assay kit nanjing jiancheng technology co
    The <t>SLC1A5-GPX4</t> axis mediates lapatinib-induced ferroptosis. (A-B) Western blot analysis of SLC1A5 protein expression in OS cells treated with Lap or Lap+DFO (100 μM). (C) Evaluation of the interaction between Lap and SLC1A5 using CETSA. (D) DARTS assay confirming the interaction between Lap and SLC1A5. (E) Viability assessment by calcein-AM (live, green)/PI (dead, red) staining in cells overexpressing SLC1A5. (F) Detection of intracellular Fe 2+ by FerroOrange probe. (G-H) Measurements of Gln and GSH levels in OS cells under indicated conditions. (I) Western blot analysis of SLC1A5 and GPX4 expression following Lap treatment in SLC1A5-overexpressing cells. (J) Western blot analysis of SLC1A5 protein expression in OS cells transfected with control siRNA or siRNA SLC1A5, showing knockdown efficiency. (K) GPX4 protein expression after lapatinib treatment for 24 h in control and SLC1A5 knockdown cells. (L) Cell viability determined by CCK-8 assay. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Assays Gpx4 Activity Assay Kit Nanjing Jiancheng Technology Co, supplied by Nanjing Jiancheng Bioengineering Research Institute Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gpx4/glutathione+gsh/pm42314685-324-18-23
    Average 86 stars, based on 1 article reviews
    assays gpx4 activity assay kit nanjing jiancheng technology co - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Abmart Inc anti gpx4
    The <t>SLC1A5-GPX4</t> axis mediates lapatinib-induced ferroptosis. (A-B) Western blot analysis of SLC1A5 protein expression in OS cells treated with Lap or Lap+DFO (100 μM). (C) Evaluation of the interaction between Lap and SLC1A5 using CETSA. (D) DARTS assay confirming the interaction between Lap and SLC1A5. (E) Viability assessment by calcein-AM (live, green)/PI (dead, red) staining in cells overexpressing SLC1A5. (F) Detection of intracellular Fe 2+ by FerroOrange probe. (G-H) Measurements of Gln and GSH levels in OS cells under indicated conditions. (I) Western blot analysis of SLC1A5 and GPX4 expression following Lap treatment in SLC1A5-overexpressing cells. (J) Western blot analysis of SLC1A5 protein expression in OS cells transfected with control siRNA or siRNA SLC1A5, showing knockdown efficiency. (K) GPX4 protein expression after lapatinib treatment for 24 h in control and SLC1A5 knockdown cells. (L) Cell viability determined by CCK-8 assay. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
    Anti Gpx4, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gpx4/anti+gpx4/pm42297177-169-8-11
    Average 86 stars, based on 1 article reviews
    anti gpx4 - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    The SLC1A5-GPX4 axis mediates lapatinib-induced ferroptosis. (A-B) Western blot analysis of SLC1A5 protein expression in OS cells treated with Lap or Lap+DFO (100 μM). (C) Evaluation of the interaction between Lap and SLC1A5 using CETSA. (D) DARTS assay confirming the interaction between Lap and SLC1A5. (E) Viability assessment by calcein-AM (live, green)/PI (dead, red) staining in cells overexpressing SLC1A5. (F) Detection of intracellular Fe 2+ by FerroOrange probe. (G-H) Measurements of Gln and GSH levels in OS cells under indicated conditions. (I) Western blot analysis of SLC1A5 and GPX4 expression following Lap treatment in SLC1A5-overexpressing cells. (J) Western blot analysis of SLC1A5 protein expression in OS cells transfected with control siRNA or siRNA SLC1A5, showing knockdown efficiency. (K) GPX4 protein expression after lapatinib treatment for 24 h in control and SLC1A5 knockdown cells. (L) Cell viability determined by CCK-8 assay. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Journal: Journal of Bone Oncology

    Article Title: Lapatinib induces ferroptosis in osteosarcoma via the SLC1A5-GPX4 axis

    doi: 10.1016/j.jbo.2026.100771

    Figure Lengend Snippet: The SLC1A5-GPX4 axis mediates lapatinib-induced ferroptosis. (A-B) Western blot analysis of SLC1A5 protein expression in OS cells treated with Lap or Lap+DFO (100 μM). (C) Evaluation of the interaction between Lap and SLC1A5 using CETSA. (D) DARTS assay confirming the interaction between Lap and SLC1A5. (E) Viability assessment by calcein-AM (live, green)/PI (dead, red) staining in cells overexpressing SLC1A5. (F) Detection of intracellular Fe 2+ by FerroOrange probe. (G-H) Measurements of Gln and GSH levels in OS cells under indicated conditions. (I) Western blot analysis of SLC1A5 and GPX4 expression following Lap treatment in SLC1A5-overexpressing cells. (J) Western blot analysis of SLC1A5 protein expression in OS cells transfected with control siRNA or siRNA SLC1A5, showing knockdown efficiency. (K) GPX4 protein expression after lapatinib treatment for 24 h in control and SLC1A5 knockdown cells. (L) Cell viability determined by CCK-8 assay. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

    Article Snippet: The membranes were blocked with 5% non-fat milk at room temperature for 1 h, then incubated overnight at 4 °C with primary antibodies against GPX4 (1:5000, Abmart, T56959 ), SLC1A5 (1:2500, Selleck, F0619), and β-actin (1:10000, Servicebio, GB11001).

    Techniques: Western Blot, Expressing, Staining, Transfection, Control, Knockdown, CCK-8 Assay

    Lapatinib induces ferroptosis by suppressing GPX4. (A-B) Western blot analysis of GPX4 protein expression in OS cells following Lap treatment. (C—D) Western blot analysis of GPX4 expression in OS cells treated with Lap and DFO (100 μM). (E-F) Assessment of cell death by propidium iodide (PI) staining following GPX4 overexpression. (G-H) Measurement of intracellular ROS levels using DCFH-DA probe. (I-J) Flow cytometric analysis of lipid ROS using C11-BODIPY probe.

    Journal: Journal of Bone Oncology

    Article Title: Lapatinib induces ferroptosis in osteosarcoma via the SLC1A5-GPX4 axis

    doi: 10.1016/j.jbo.2026.100771

    Figure Lengend Snippet: Lapatinib induces ferroptosis by suppressing GPX4. (A-B) Western blot analysis of GPX4 protein expression in OS cells following Lap treatment. (C—D) Western blot analysis of GPX4 expression in OS cells treated with Lap and DFO (100 μM). (E-F) Assessment of cell death by propidium iodide (PI) staining following GPX4 overexpression. (G-H) Measurement of intracellular ROS levels using DCFH-DA probe. (I-J) Flow cytometric analysis of lipid ROS using C11-BODIPY probe.

    Article Snippet: The membranes were blocked with 5% non-fat milk at room temperature for 1 h, then incubated overnight at 4 °C with primary antibodies against GPX4 (1:5000, Abmart, T56959 ), SLC1A5 (1:2500, Selleck, F0619), and β-actin (1:10000, Servicebio, GB11001).

    Techniques: Western Blot, Expressing, Staining, Over Expression

    Lapatinib suppresses tumor growth by activating ferroptosis in vivo. (A) Experimental timeline for in vivo administration of Lap (25 mg/kg, i.p., daily) and DFO (10 mg/kg, i.p., daily). (B—C) Representative photographs of resected xenograft tumors from each group ( n = 4) (Scale bar: 1 cm). (D-E) Tumor weight and volume at the study endpoint. (F-G) Curves depicting body weight changes and tumor growth over time. (H) Hematoxylin and eosin (H&E) staining and immunohistochemical (IHC) analysis of tumor sections (scale bar: 50 μm). (I) Western blot analysis of SLC1A5 and GPX4 protein levels in tumor tissues. (J-K) Measurement of GSH and MDA levels in mouse plasma.

    Journal: Journal of Bone Oncology

    Article Title: Lapatinib induces ferroptosis in osteosarcoma via the SLC1A5-GPX4 axis

    doi: 10.1016/j.jbo.2026.100771

    Figure Lengend Snippet: Lapatinib suppresses tumor growth by activating ferroptosis in vivo. (A) Experimental timeline for in vivo administration of Lap (25 mg/kg, i.p., daily) and DFO (10 mg/kg, i.p., daily). (B—C) Representative photographs of resected xenograft tumors from each group ( n = 4) (Scale bar: 1 cm). (D-E) Tumor weight and volume at the study endpoint. (F-G) Curves depicting body weight changes and tumor growth over time. (H) Hematoxylin and eosin (H&E) staining and immunohistochemical (IHC) analysis of tumor sections (scale bar: 50 μm). (I) Western blot analysis of SLC1A5 and GPX4 protein levels in tumor tissues. (J-K) Measurement of GSH and MDA levels in mouse plasma.

    Article Snippet: The membranes were blocked with 5% non-fat milk at room temperature for 1 h, then incubated overnight at 4 °C with primary antibodies against GPX4 (1:5000, Abmart, T56959 ), SLC1A5 (1:2500, Selleck, F0619), and β-actin (1:10000, Servicebio, GB11001).

    Techniques: In Vivo, Staining, Immunohistochemical staining, Western Blot, Clinical Proteomics